Th17 cells characterized by high IL-17A and GM-CSF expression are enriched and clonally expanded in the lungs of COVID-19 patients with severe disease, potentially contributing to lung damage through interacting with CD8+ T cells and macrophages [22]. This evidence concerns the gene IL17A and COVID-19.